Intimation of Monitoring Agency Report for the quarter ended March 31, 2026.
LAXMIDENTL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Laxmi Dental's monitoring agency ICRA has submitted its Q4 FY2026 report on IPO proceeds utilization. The company raised INR 138 crore in its January 2025 IPO and has utilized INR 83.33 crore (60.4%) as of March 31, 2026, leaving INR 54.67 crore unutilized. The unutilized funds are deployed in fixed deposits with banks. Borrowings repayment (INR 22.98 crore) and general corporate purposes (INR 32.08 crore) have been fully utilized. However, capital expenditure for machinery is lagging at INR 13.50 crore of INR 43.51 crore, while investment in subsidiary Bizdent Devices stands at just INR 0.35 crore of INR 25 crore. ICRA confirms no material deviation from the IPO objects and all utilization is in line with the offer document disclosures.
The report is broadly positive for investors as the monitoring agency confirms no material deviation in fund utilization. The slower-than-expected capital expenditure deployment (particularly for the subsidiary Bizdent) may extend the timeline for expected capacity expansion, though this is not a compliance concern.